Document is current
Any future updates will be listed below
-
Authors
Wani, Agaz H.
Katrinli, Seyma
Zhao, Xiang
Daskalakis, Nikolaos P.
Zannas, Anthony S.
Aiello, Allison E.
Baker, Dewleen G.
Boks, Marco P.
Brick, Leslie A.
Chen, Chia-Yen
Dalvie, Shareefa
Fortier, Catherine
Geuze, Elbert
Hayes, Jasmeet P.
Kessler, Ronald C.
King, Anthony P.
Koen, Nastassja
Liberzon, Israel
Lori, Adriana
Luykx, Jurjen J.
Maihofer, Adam X.
Milberg, William
Miller, Mark W.
Mufford, Mary S.
Nugent, Nicole R.
Rauch, Sheila
Ressler, Kerry J.
Risbrough, Victoria B.
Rutten, Bart P. F.
Stein, Dan J.
Stein, Murray B.
Ursano, Robert J.
Verfaellie, Mieke H.
Vermetten, Eric
Vinkers, Christiaan H.
Ware, Erin B.
Wildman, Derek E.
Wolf, Erika J.
Nievergelt, Caroline M.
Logue, Mark W.
Smith, Alicia K.
Uddin, Monica
-
Funding
Funding for this research was provided by:
National Institutes of Health, United States (K12HD085850)
National Institutes for Minority Health and Health Disparities (R01MD011728, R01MD011728, R01MD011728)
VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center (B3001-C)
National Institute of Mental Health (K23MH112852, R01MH105379, U01MH087981, U01MH087981)
U.S. Department of Defense (#W81XWH-11-1-0073)
National Center for Advancing Translational Sciences (UL1TR000433)
National Institutes of Health (R01MH106595, R01MH106595, R01MH106595)
U.S. Department of Veterans Affairs (BX005872, I01 CX-001276-01)
The Dutch Research Council (917.18.336)
Bill and Melinda Gates Foundation (OPP 1017641)
The National Institute of Aging, United States (RF1AG068121)
The National Institute of Mental Health (R01MH108826, R01MH108826, R01MH108826, R01MH108826)
- License Information
-
More Information
Article History
Received: 12 February 2024
Accepted: 29 August 2024
First Online: 27 September 2024
Declarations
:
: All participants included in analyses of the discovery and external validation cohorts provided informed consent for their participation. Details on the specific IRB approval associated with each study are provided in the Supplementary Material.
: Not applicable.
: Murray B. Stein has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Biogen, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Delix Therapeutics, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sage Therapeutics, Sumitomo Pharma, and Roche/Genentech. Dr. Stein has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. Dr. Chia-Yen Chen is an employee of Biogen. Dr. Nikolaos P. Daskalakis has served on scientific advisory boards for BioVie Pharma, Circular Genomics and Sentio Solutions for unrelated work. Dr. Nicole R. Nugent is a member of the scientific advisory board for Ilumivu. Dr. Sheila Rauch support from Wounded Warrior Project (WWP), Department of Veterans Affairs (VA), National Institute of Health (NIH), McCormick Foundation, Tonix Pharmaceuticals, Woodruff Foundation, and Department of Defense (DOD). Dr. Rauch also receives royalties from Oxford University Press and American Psychological Association Press. Dr Ressler reported receiving personal consulting fees from Sage Therapeutics, Senseye, Boerhinger Ingelheim, Jazz Pharmaceuticals, and Acer, Inc. and a sponsored research grant from Alto Neuroscience outside the submitted work.
